Marketwatch Can Sputnik V approval bring big gains to Dr Reddy’s stock? Admin April 13, 2021 Analysts said Dr Reddy’s Labs has exclusive distribution rights for the first 250 million doses in India. – Stocks-Markets-Economic Times Share on Facebook Tweet it Pin it Share it Email
